Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Surgery for Gummy Smile
NCT03186547Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of botulinum toxin type A in excessive gingival display (2 arms), sponsored by Cairo University. Primary endpoints: Patient satisfaction at 4 weeks and Postoperative side effects at 4 weeks. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT03186547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186547.